Jack A. Khattar - 30 Jul 2021 Form 4/A - Amendment Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role: President, CEO, Director
Signature: /s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol: SUPN
Transactions as of: 30 Jul 2021
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 13 Jan 2023, 16:00:25 UTC
Date Of Original Report: 30 Jul 2021
Previous filing: 10 Jun 2021
Next filing: 07 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	SUPN	Common Stock						516,466	30 Jul 2021	Direct
holding	SUPN	Common Stock						1,058,450	30 Jul 2021	By the KBT Trust
holding	SUPN	Common Stock						4,000	30 Jul 2021	By Son	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SUPN	Performance Share Unit	Award	$0	+40,000		$0.000000	40,000	30 Jul 2021	Common Stock	40,000	$0.000000	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person disclaims beneficial ownership of the shares held by his son, who shares the Reporting Person's household, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his son's shares for purposes of Section 16 or for any other purpose.
F2	On February 19, 2021, the Reporting Person was awarded Performance Shares Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period.